3.15 (1.1%)
3.3 (1.15%) 11.57 am | 09 Feb 2012 | Source: CNBC-TV18
Biocon has target of Rs 296, says Amit Gupta, Head-Derivatives -ICICI Direct....
11.28 am | 06 Feb 2012 | Source: CNBC-TV18
Enter Biocon, says Hemant Thukral, National Head-Derivative Desk, Aditya Birla Money....
9.17 am | 06 Feb 2012 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Biocon....
8.36 am | 06 Feb 2012 | Source: CNBC-TV18
On CNBC-TV18's new show Super Six, market gurus Hemen Kapadia of chartpundit.com, Nooresh Merani of AMSEC Research and Arunesh Madan, Founder and Dire...
8.28 am | 06 Feb 2012 | Source: CNBC-TV18
The market closed last week with a flourish. The Nifty ended above the 5,300 mark. Sudarshan Sukhani, s2analytics.com says, the market has rallied dec...
3.38 pm | 01 Feb 2012 | Source: Moneycontrol.com
Sushil Finance is bullish on Biocon and has recommended buy rating on the stock with a target price of Rs 325 in its January 30, 2012 research report....
11.22 am | 31 Jan 2012 | Source: Moneycontrol.com
Unicon Investment is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 320 in its January 30, 2012 research report....
1.54 pm | 30 Jan 2012 | Source: Moneycontrol.com
Dolat Capital is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 373 in its January 25, 2012 research report....
11.58 am | 27 Jan 2012 | Source: Moneycontrol.com
Biocon has reported a sales turnover of Rs 386.12 crore and a net profit of Rs 64.73 crore for the quarter ended Dec '11...
11.02 am | 25 Jan 2012 | Source: Reuters
Biocon, India's top-listed biotechnology company, expects to generate larger licensing income from pharmaceuticals business, its Chairman and Managing...
9.13 am | 24 Jan 2012 | Source: CNBC-TV18
Pharmaceutical firm Biocon is likely to post a profit after tax of Rs 94 crore in the third quarter of FY12, a growth of 10% as compared to Rs 86 cror...
11.50 am | 18 Jan 2012 | Source: Moneycontrol.com
IIFL is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 276 in its January 18, 2012 research report....
9.13 am | 18 Jan 2012 | Source: CNBC-TV18
Sudarshan Sukhani, s2analytics.com feels that there is more upside in Idea....
8.58 am | 18 Jan 2012 | Source: CNBC-TV18
Sudarshan Sukhani of s2analystics spoke to CNBC-TV18 about where the market is likely to go today and what are the best ways to play the rally....
9.09 am | 13 Jan 2012 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com one can short Biocon....
8.22 am | 13 Jan 2012 | Source: CNBC-TV18
Sudarshan Sukhani, s2analytics.com says, the short term-trend is still up. “Trader can take long positions,” he advises....
8.40 am | 09 Jan 2012 | Source: Moneycontrol.com
ICICIdirect.com has come out with its report on Nifty Future, Bank of India (BOI), Polaris Software, Biocon and IDFC...
4.07 pm | 07 Dec 2011 | Source: Moneycontrol.com
GEPL Capital has come out with its report on top trading picks. The research firm recommends buying Ashok Leyland, Jubilant Food and selling Biocon....
3.32 pm | 01 Dec 2011 | Source: Moneycontrol.com
Dolat Capital is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 421 in its December 1, 2011 research report....
1.43 pm | 16 Nov 2011 | Source: Moneycontrol.com
According to IIFL, traders can sell Biocon November future below Rs 325 with stop loss of Rs 331 for target of Rs 313, in its November 16, 2011 resear...
|
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Mitt Romney | Bharti Airtel | BSE Sensex | Uninor | Iran | EGoM | Aviation | Thomas Cook | Mahindra and Mahindra Limited | Temasek Holdings